secwatch.observer — SEC 8-K summary
======================================

Issuer:     CG Oncology, Inc. (CGON)
CIK:        0001991792
Form:       8-K
Filed at:   2025-09-09T23:59:59+00:00
Accession:  0001991792-25-000007
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CG Oncology presents updated corporate deck at Morgan Stanley conference; no specifics in filing excerpt
--------------------------------------------------------------------------------

- The filing references a corporate presentation (Exhibit 99.1) provided at the Sept 9, 2025 Morgan Stanley conference.
- Only a tagline and partial disclaimer header appear in the exhibit excerpt; no new clinical or financial data are visible.
- No material changes or specific milestones were disclosed in the 8-K text itself.
- Investors should seek the full presentation for any updated pipeline or financial information.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1991792/000199179225000007/0001991792-25-000007-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1991792/000199179225000007/ck0001991792-20250909.htm
  HTML page:      https://secwatch.observer/filing/0001991792-25-000007

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer